Laura Dowling

Now, it's full of statistics.

But that's why I have you to read it for me and tell me what I need to know.

It's all about the gender bias gap in data.

So it's basically about the fact that the world...

Now, not deliberately, but the world is built for men, be it from a policy point of view, from even infrastructure, from medicine, that it's built for your average man.

And if we ever go any deeper, it's usually your average white man.

So even if we talk about infrastructure, we don't take into consideration if we're town planning that women will often have, if they're going into work,

they will have to go to the creche to drop their kids off, maybe to the shops, then go into work.

And then, you know, a few stops in the way.

We plan it for straight line commuting.

So it's planned for a man to go from his house to work and back.

We don't take into consideration in medicine how women are not just small men.

We're actually physiologically very different.

And up until very recently, women were excluded from clinical trials because of our menstrual cycle.

causing I suppose changes in our own bodies and the way we would react to normal life.

The pharma companies were worried that if they throw in a menstrual cycle in on top of a drug clinical trial that it will throw up these anomalies that may or may not be associated with the drug so it will just cause more money.

more time to actually gather the data for it.

So in medicine, it's huge.

And it was only in 1994 that it was, pharma companies had to include women in clinical trials.

Up until then, most clinical trials were done on men.